NALIN S SONI

Allopathic & Osteopathic Physicians|Internal Medicine FRANKLIN, WI NPI 1346353885

General Payments — all program years on this page

$1,149.09

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $265.40 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $265.4021

By paying entity

Latest program year (PY2019) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $883.6948
2019 $265.4021

Records — PY2019 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
630301979 Kowa Pharmaceuticals America, Inc. $13.60 05/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
658061847 Lilly USA, LLC $14.88 06/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
662811369 Amgen Inc. $16.46 02/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671171769 Allergan Inc. $11.26 03/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671171773 Allergan Inc. $11.82 07/01/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671171777 Allergan Inc. $10.84 08/20/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671547701 GlaxoSmithKline, LLC. $15.74 01/29/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673800665 PFIZER INC. $21.66 08/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
673823175 PFIZER INC. $12.00 05/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681910107 Takeda Pharmaceuticals U.S.A., Inc. $11.46 06/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
681964823 Takeda Pharmaceuticals U.S.A., Inc. $0.30 06/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
688752023 AstraZeneca Pharmaceuticals LP $12.22 02/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
688761967 AstraZeneca Pharmaceuticals LP $11.13 04/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
688772053 AstraZeneca Pharmaceuticals LP $11.08 07/10/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
695518659 Merck Sharp & Dohme Corporation $13.31 05/28/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
695594535 Merck Sharp & Dohme Corporation $11.13 06/19/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700196503 Boehringer Ingelheim Pharmaceuticals, Inc. $13.32 07/03/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700196505 Boehringer Ingelheim Pharmaceuticals, Inc. $15.21 02/19/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700196507 Boehringer Ingelheim Pharmaceuticals, Inc. $16.12 06/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
707555921 Ironshore Pharmaceuticals Inc. $10.93 08/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
707555923 Ironshore Pharmaceuticals Inc. $10.93 08/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.